Macquarie Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$196M Buy
600,111
+527,519
+727% +$172M 0.24% 71
2025
Q1
$19.6M Buy
72,592
+11,928
+20% +$3.22M 0.02% 660
2024
Q4
$14.3M Sell
60,664
-11,952
-16% -$2.81M 0.02% 732
2024
Q3
$20M Buy
72,616
+13,161
+22% +$3.62M 0.02% 668
2024
Q2
$14.4M Buy
59,455
+3,548
+6% +$862K 0.02% 732
2024
Q1
$8.36M Buy
55,907
+8,890
+19% +$1.33M 0.01% 862
2023
Q4
$9M Buy
47,017
+1,111
+2% +$213K 0.01% 848
2023
Q3
$8.13M Buy
45,906
+882
+2% +$156K 0.01% 830
2023
Q2
$8.55M Sell
45,024
-705
-2% -$134K 0.01% 831
2023
Q1
$9.16M Buy
45,729
+511
+1% +$102K 0.01% 822
2022
Q4
$10.7M Buy
45,218
+934
+2% +$222K 0.01% 820
2022
Q3
$8.86M Buy
44,284
+1,352
+3% +$271K 0.01% 859
2022
Q2
$6.26M Sell
42,932
-279
-0.6% -$40.7K 0.01% 980
2022
Q1
$7.06K Buy
43,211
+96
+0.2% +$16 0.01% 1023
2021
Q4
$7.31M Sell
43,115
-10,478
-20% -$1.78M 0.01% 1021
2021
Q3
$10.1M Hold
53,593
0.01% 918
2021
Q2
$9.09M Buy
53,593
+100
+0.2% +$17K 0.01% 964
2021
Q1
$7.55M Buy
53,493
+10,198
+24% +$1.44M 0.01% 802
2020
Q4
$5.63M Sell
43,295
-842
-2% -$109K 0.01% 856
2020
Q3
$6.43M Sell
44,137
-10,610
-19% -$1.54M 0.01% 757
2020
Q2
$8.11M Sell
54,747
-1,556
-3% -$230K 0.01% 667
2020
Q1
$6.13M Sell
56,303
-2,875
-5% -$313K 0.01% 670
2019
Q4
$6.82M Buy
59,178
+103
+0.2% +$11.9K 0.01% 727
2019
Q3
$4.75M Sell
59,075
-3,213
-5% -$258K 0.01% 780
2019
Q2
$4.52M Buy
62,288
+4,215
+7% +$306K 0.01% 802
2019
Q1
$5.43M Buy
58,073
+220
+0.4% +$20.6K 0.01% 762
2018
Q4
$4.22M Buy
57,853
+438
+0.8% +$31.9K 0.01% 790
2018
Q3
$5.03M Buy
57,415
+784
+1% +$68.6K 0.01% 790
2018
Q2
$5.58M Buy
56,631
+13,747
+32% +$1.35M 0.01% 754
2018
Q1
$5.11M Buy
42,884
+1,958
+5% +$233K 0.01% 744
2017
Q4
$5.2M Buy
40,926
+27,914
+215% +$3.55M 0.01% 776
2017
Q3
$1.53M Sell
13,012
-2,649
-17% -$311K ﹤0.01% 1068
2017
Q2
$1.25M Sell
15,661
-1,608
-9% -$128K ﹤0.01% 1099
2017
Q1
$885K Sell
17,269
-486
-3% -$24.9K ﹤0.01% 1209
2016
Q4
$665K Buy
17,755
+1,614
+10% +$60.5K ﹤0.01% 1266
2016
Q3
$1.09M Sell
16,141
-24,145
-60% -$1.64M ﹤0.01% 1125
2016
Q2
$2.24M Buy
40,286
+39,386
+4,376% +$2.19M ﹤0.01% 1115
2016
Q1
$56K Hold
900
﹤0.01% 1466
2015
Q4
$85K Hold
900
﹤0.01% 1425
2015
Q3
$72K Sell
900
-14,384
-94% -$1.15M ﹤0.01% 1510
2015
Q2
$1.83M Sell
15,284
-4,587
-23% -$550K ﹤0.01% 1045
2015
Q1
$2.08M Sell
19,871
-6,167
-24% -$644K ﹤0.01% 1013
2014
Q4
$2.53M Sell
26,038
-1,994
-7% -$193K 0.01% 944
2014
Q3
$2.19M Sell
28,032
-2,000
-7% -$156K ﹤0.01% 965
2014
Q2
$1.9M Buy
30,032
+2,828
+10% +$179K ﹤0.01% 1057
2014
Q1
$1.83M Sell
27,204
-15,646
-37% -$1.05M ﹤0.01% 1040
2013
Q4
$2.76M Buy
42,850
+16,759
+64% +$1.08M ﹤0.01% 844
2013
Q3
$1.67M Buy
26,091
+8,091
+45% +$518K ﹤0.01% 1012
2013
Q2
$558K Buy
+18,000
New +$558K ﹤0.01% 1261